•
Jun 30, 2018

CRISPR Therapeutics Q2 2018 Earnings Report

Total Revenue
$1.09M
Previous year: $3.58M
-69.6%
EPS
-$0.82
Previous year: -$0.56
+46.4%
Gross Profit
-$24.5M
Previous year: -$13.5M
+81.3%
Cash and Equivalents
$320M
Previous year: $272M
+17.4%
Free Cash Flow
-$25.7M
Previous year: -$40.7M
-36.8%
Total Assets
$353M
Previous year: $305M
+15.8%

CRISPR Therapeutics

CRISPR Therapeutics